Semax is a synthetic heptapeptide derived from an adrenocorticotropic hormone (ACTH) fragment, widely explored in research for its potential neurotropic and neuroprotective properties.

Studies frequently investigate Semax in models of cognitive function, neuroplasticity, and stress response, including its influence on BDNF expression, learning processes, and recovery in neurological research settings.

This compound is provided as a lyophilized powder.